Welcome to the
Hepatitis B Foundation
Social Media Tools to Help You Observe Hepatitis Awareness Month
May 4 – May is Hepatitis Awareness Month, providing us with 31 days to raise awareness of viral hepatitis in the United States. Awareness activities will take place throughout the month, with Tuesday, May 19th designated as National Hepatitis Testing Day. Check out resources and events for the month, and help raise awareness! Read more.
Tenofovir DF Prevents Vertical Transmission in Mothers With Lamivudine-Resistant HBV
May 4 – Tenofovir (TDF) safely and effectively blocks vertical transmission of hepatitis B in mothers with lamivudine-resistant HBV strains and was well tolerated by pregnant women in their second and third trimesters, according to a study presented at EASL. Read more.
Female Student Isolated for Carrying HBV, Commits Suicide
May 4 – Shunned by students and faculty, a freshman college student with chronic hepatitis B takes her life, despite a Chinese Ministry of Health ruling against discrimination of those with chronic HBV. Education and awareness is essential to eliminate the stigma of hepatitis B. Read more.
Tenofovir Cessation After Long-Term Treatment in HBV-Infected Patients Associated With Greater Decline in HBsAg
May 4 – Stopping tenofovir (TDF) treatment after long-term virologic suppression is safe and associated with a more profound decline in hepatitis B surface antigen levels than continuous treatment in patients with hepatitis B e antigen-negative chronic hepatitis B who have undetectable HBV DNA, according to a study presented at EASL. Read more.
HBF’s Baruch S. Blumberg Institute Partners with University of Pennsylvania for Masters of Chemical Sciences Program
May 1 – The Baruch S. Blumberg Institute, the research arm of the HBF, has finalized an agreement that allows University of Pennsylvania chemistry graduate students to complete their research at the Institute. This will bring high-caliber research support to the Blumberg Institute, while providing real-world research experience to the students. Read more.
Dr. Eugene Schiff Receives Hepatitis B Foundation’s Highest Scientific Honor
April 20 – The 2015 Crystal Ball Gala, hosted by the Hepatitis B Foundation, was a huge success, and included an evening of dinner, dancing, live and silent auctions, a mission moment, and the awarding of the Baruch S. Blumberg Prize to Dr. Eugene Schiff for advancing the care and treatment of chronic hepatitis B. Read more.
Institute Assembles Team of 'All-Star Researchers' to Cure Hepatitis B
April 6– The Baruch S. Blumberg Institute has recruited a new team of nationally renowned, “all Star researchers” who will focus exclusively on developing a cure for hepatitis B, with a goal for breakthrough therapies within the next three years. Read more.
Page last modified May 4, 2015